YIPF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.06268377115293E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.72084568816899E-12 |
Normal-vs-Stage2 |
7.80659999977118E-07 |
Normal-vs-Stage3 |
1.807580E-04 |
Normal-vs-Stage4 |
8.698200E-02 |
Stage1-vs-Stage2 |
1.521650E-01 |
Stage1-vs-Stage3 |
2.269600E-02 |
Stage1-vs-Stage4 |
2.619000E-01 |
Stage2-vs-Stage3 |
5.926400E-01 |
Stage2-vs-Stage4 |
6.485000E-01 |
Stage3-vs-Stage4 |
8.559400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.23880938629873E-12 |
Normal-vs-AfricanAmerican |
1.16920029213929E-10 |
Normal-vs-Asian |
4.301200E-01 |
Caucasian-vs-AfricanAmerican |
5.027200E-01 |
Caucasian-vs-Asian |
8.784100E-02 |
AfricanAmerican-vs-Asian |
4.059600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6251444634463E-12 |
Normal-vs-Female |
2.375300E-04 |
Male-vs-Female |
1.58859999999095E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.00919999526761E-08 |
Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
Normal-vs-Obese |
1.866900000147E-07 |
Normal-vs-Extreme_Obese |
1.627410E-04 |
Normal_Weight-vs-Extreme_Weight |
5.907800E-02 |
Normal_Weight-vs-Obese |
6.092000E-01 |
Normal_Weight-vs-Extreme_Obese |
8.259800E-01 |
Extreme_Weight-vs-Obese |
1.231920E-02 |
Extreme_Weight-vs-Extreme_Obese |
1.063830E-01 |
Obese-vs-Extreme_Obese |
9.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.303000E-01 |
Normal-vs-Age(41-60Yrs) |
2.54699594748331E-11 |
Normal-vs-Age(61-80Yrs) |
3.33066907387547E-13 |
Normal-vs-Age(81-100Yrs) |
1.37720000004116E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.483960E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.890300E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.302190E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.158600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.327400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
1.83199999947981E-07 |
Normal-VS-KIRP CIMP |
8.626000E-01 |
Normal-VS-Unclassified PRCC |
1.56757999999479E-05 |
Type1 PRCC-VS-Type2 PRCC |
3.757000E-04 |
Type1 PRCC-VS-KIRP CIMP |
2.488400E-02 |
Type1 PRCC-VS-Unclassified PRCC |
3.962800E-03 |
Type2 PRCC-VS-KIRP CIMP |
1.084810E-01 |
Type2 PRCC-VS-Unclassified PRCC |
8.475600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.923600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.80889747625201E-11 |
Normal-vs-N1 |
1.096770E-01 |
Normal-vs-N2 |
8.888200E-01 |
N0-vs-N1 |
2.248000E-02 |
N0-vs-N2 |
7.539900E-03 |
N1-vs-N2 |
5.854400E-01 |
|
|